Header Logo

Connection

Christopher Goetz to Pyridines

Back to Details
This is a "connection" page, showing publications Christopher Goetz has written about Pyridines.
Christopher Goetz
Connection Strength
0.133
Pyridines
  1. A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. Mov Disord. 2016 09; 31(9):1373-80.
    View in: PubMed
    Score: 0.133
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.